BrainTrip
BrainTrip is a Malta-incorporated, Slovenia-based medical device company whose NeuroAI platform converts EEG recordings into cognitive-health (CogniScore) and brain-age (BrainAge) biomarkers, sold through direct enterprise demos to clinics, hospitals, research labs, longevity centers, and pharma buyers.
- Company typePrivate
- Founded2019
- HeadquartersLjubljana, Slovenia
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What BrainTrip does
BrainTrip is a Slovenia-founded, Malta-incorporated medical device company that sells NeuroAI, a software-and-hardware platform for translating EEG brain-wave data into objective biomarkers of brain function. The company's two commercial products are CogniScore, an EEG-based cognitive health test that quantifies brain health on a 0–100 score and flags cognitive decline or dementia with reported 96% specificity and 88% sensitivity, and BrainAge, an EEG-based brain biological clock that estimates brain age with a stated typical error of 1.6 years and corrects for confounders such as sex and education. Both products run on a portable 24-channel EEG system that fits into a suitcase, require roughly five hours of onboarding rather than months of training, and are designed for point-of-care use by clinicians without prior EEG expertise; data is processed in the cloud under GDPR-compliant controls.
The underlying NeuroAI engine is described as a virtual neuroscientist that pairs traditional EEG signal processing with machine learning trained on more than 1,500 EEG recordings across 500 subjects, from which the company claims to have identified 400 predictive biomarkers drawn from 100 million candidate brain-wave features. CogniScore is CE-marked as an EU medical device; BrainAge is positioned for preventive-care, longevity, and clinical research use. Go-to-market is a direct enterprise sales motion using online demo booking, selling to clinics, hospitals, research labs, longevity and wellness facilities, and pharmaceutical customers, with stated intent to extend into drug discovery, personalized medicine, and large-scale neuroscience research. Revenue mechanics are not publicly disclosed but appear to combine hardware sale of the portable EEG kit with recurring cloud-analysis fees; pricing is quote-based with multi-year institutional contracts and no published tiers.
The company is privately held under BrainTrip Limited (Malta), employs 1–10 people, was founded in 2019 by co-founders Jurij and David out of a neuroscience lab, and has publicly disclosed only one funding event (Fast Track Malmo, March 2020). Its commercial track record relies heavily on credibility signals — winner of the EIB Social Innovation Tournament 2023 (one of 23 Global Innovators from 7,000+ applicants), finalist at Fundación MAPFRE Social Outreach Awards, and recipient of the European Award in Medicine 2024 — rather than named enterprise customers, disclosed revenue, or follow-on institutional capital.
BrainTrip firmographics
Firmographics- Name
- BrainTrip
- Legal name
- BrainTrip Limited
- Website
- https://braintrip.net
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BrainTrip is a Malta-incorporated, Slovenia-based medical device company whose NeuroAI platform converts EEG recordings into cognitive-health (CogniScore) and brain-age (BrainAge) biomarkers, sold through direct enterprise demos to clinics, hospitals, research labs, longevity centers, and pharma buyers.
- Ownership category
- akta.pro rank
BrainTrip industry classification
Industry- Product category
- Neurodiagnostic Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industry
- Neurology Telemedicine Platforms (HLALAGAC)
Keywords
Where BrainTrip is headquartered
LocationHeadquarters
- HQ city
- Ljubljana
- HQ country
- Slovenia
- HQ region
- Europe
Offices1 record
Markets served
BrainTrip business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- NeuroAI Medical Devices: Sale of CE-marked medical devices (CogniScore and BrainAge) that include EEG hardware systems and associated software analysis. The portable systems (fitting into suitcases) are sold to healthcare institutions, clinics, and labs for point-of-care brain diagnostics.
- Cloud-based EEG Analysis Software: SaaS-style recurring revenue from cloud processing of EEG data. The system performs automatic data cleaning, biomarker analysis, and produces results within minutes, suggesting a subscription or per-test model for the AI analysis component.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/B2B pricing through demo inquiry |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
BrainTrip product offering
Product offeringCore offering
BrainTrip develops and sells the NeuroAI platform, an AI-driven brain wave analysis system that processes EEG recordings into diagnostic biomarkers. Built on this platform are two CE-marked medical device products: CogniScore, which quantifies cognitive health and detects cognitive decline or dementia on a 0-100 scale using 400 predictive biomarkers, and BrainAge, which estimates brain biological age from EEG recordings with 1.6-year typical error.
Product overview
BrainTrip offers a platform-plus-products architecture centered on its NeuroAI technology, a virtual neuroscientist that processes EEG brain-wave data. The company provides two distinct diagnostic products built on this platform: CogniScore, which quantifies cognitive health and detects dementia/cognitive decline with a 0-100 score, and BrainAge, which measures the brain's biological age. Both products are designed for point-of-care use, fitting into portable suitcase systems and requiring minimal training to operate.
Differentiator
Problem solved
Functional benefit
Brands
- NeuroAI: Virtual neuroscientist platform that processes complex brain-wave data and produces easy-to-understand results for brain health diagnostics.
- CogniScore
- BrainAge
Quantifiable outcome
- 95% accuracy with 96% specificity and 88% sensitivity for cognitive assessment
- +3 more outcomes
Companies that use BrainTrip
Customer profileSegments4 records
Ideal customer profiles4 records
BrainTrip technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
BrainTrip partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
BrainTrip competitors and assessment
Company assessmentDirect peers
- Cumulus Neuroscience: Provides EEG-based multimodal assessment platforms for neurological and psychiatric conditions in clinical trials and clinical practice. Direct overlap with BrainTrip in using EEG + AI to quantify brain function and track cognitive change.
- Linus Health: Digital cognitive assessment platform using AI to detect early signs of cognitive impairment and dementia. Competes for the same clinical and longevity channel customers as CogniScore, with a software-first delivery model.
- Altoida: Digital neurocognitive assessment platform leveraging smartphone/AR-based tasks and AI to predict conversion to Alzheimer's. Overlaps with BrainTrip in objective, AI-driven cognitive screening for early dementia detection.
- Beacon Biosignals: AI-driven EEG analytics platform focused on clinical trials and CNS drug development, offering objective biomarkers for neurological conditions. Highly comparable to BrainTrip's pharma/drug-discovery use case.
- MyndYou: AI-based cognitive assessment and monitoring solution that analyzes speech and behavioral patterns to detect cognitive decline. Targets similar clinical and aging-services customers as BrainTrip's CogniScore.
- iMediSync: Develops AI-enabled EEG diagnostic devices for early detection of neurological conditions including Alzheimer's and dementia. Direct overlap with BrainTrip in portable EEG + AI for cognitive diagnostics.
- Advanced Brain Monitoring: Develops clinical-grade EEG systems and applies machine learning to brain data for neurological and sleep disorder assessment. Comparable in combining proprietary EEG hardware with AI-based analytics.
Emerging players
- EMOTIV: Maker of consumer and research-grade EEG headsets with cloud-based AI analysis of brain activity. Overlaps with BrainTrip in EEG hardware + cloud AI but is more research/consumer focused than clinical.
- Neurable: EEG-based brain-computer interface company building neurotechnology for everyday use, including focus and mental wellness products. Comparable technology stack (EEG + AI) targeting adjacent consumer/wellness use cases.
- Dreem: EEG-based sleep and cognitive monitoring headband with cloud analytics. Comparable in EEG + AI architecture and adjacent in sleep and mental wellness applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
BrainTrip social profiles
Digital presenceBrainTrip compliance and trust
Trust signalCompliance2 records
BrainTrip financial estimates
Financial estimateRevenue estimate
Valuation estimate
BrainTrip leadership team
Management profileNumber of profiles
Profiles2 records
BrainTrip funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BrainTrip M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BrainTrip
What does BrainTrip do?
BrainTrip develops and sells the NeuroAI platform, an AI-driven brain wave analysis system that processes EEG recordings into diagnostic biomarkers. Built on this platform are two CE-marked medical device products: CogniScore, which quantifies cognitive health and detects cognitive decline or dementia on a 0-100 scale using 400 predictive biomarkers, and BrainAge, which estimates brain biological age from EEG recordings with 1.6-year typical error.
Is BrainTrip a public or private company?
BrainTrip is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BrainTrip founded?
BrainTrip was founded in 2019. It employs 1 to 10 people.
Where is BrainTrip based?
BrainTrip is headquartered in Ljubljana, Slovenia, in the Europe region.
How does BrainTrip make money?
Two revenue lines are on record. NeuroAI Medical Devices are the primary driver. The others are cloud-based EEG Analysis Software.
Who are BrainTrip's main competitors?
Direct peers on record are Cumulus Neuroscience, Linus Health, Altoida, Beacon Biosignals, MyndYou, iMediSync and Advanced Brain Monitoring. Emerging players are EMOTIV, Neurable and Dreem.
Does BrainTrip have an API?
No public API is recorded for BrainTrip.
What industry is BrainTrip in?
BrainTrip's product category is Neurodiagnostic Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLALAGAC, Neurology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3826.